Learning points
• The inter-arterial anomalous course of the left main coronary artery originating from the right coronary sinus of Valsalva is a rare, though potentially lethal pathology.
• Care should be taken in selecting the best revascularization strategy in patients with anomalous anatomy to best protect against the potentially lethal outcomes of the disease.
• Patients without flow limiting atherosclerotic disease may carry an additional risk of bypass graft atresia due to preserved native coronary flow.
Introduction
The inter-arterial anomalous course of the left main coronary artery (LMCA) originating from the right coronary sinus of Valsalva is a rare, though potentially lethal pathology. Due to the significant risk of abrupt LMCA occlusion, surgical correction is warranted even in the absence of symptoms. Coronary artery bypass grafting exists as a potential surgical therapy with previously reported success, however, there is concern for graft occlusion in the setting of competitive native vessel flow. We present the first documented case of a patient with spontaneous recanalization of an occluded left internal mammary artery (LIMA) graft following bypass corrective surgery for an inter-arterial anomalous course of the LMCA.
Timeline Case presentation
A 48-year-old non-smoking gentleman presented to our facility with severe dyspnoea during a 10 km run. He had no significant personal or family history of coronary disease, and denied a history of diabetes, hypertension, or hyperlipidaemia. Vital signs were within normal limits and cardiovascular examination was normal. Initial Troponin T was 217 ng/L (0-14) and serial electrocardiograms demonstrated sinus rhythm without ST segment or T wave abnormalities. Transthoracic echocardiography demonstrated normal biventricular size and systolic function with normal valvular function and no regional wall motion abnormalities. A provisional diagnosis of non-ST elevation myocardial infarction was made. The patient underwent coronary angiography, which demonstrated patent coronary arteries, with difficult engagement of the LMCA due to an abnormal origin. The left main ostium had an abnormal appearance, which did not significantly change following the administration of intracoronary glyceryltrinitrate ( Figure 1) .
Subsequent clarification was sought with computed tomography of the coronary arteries (CTCA), which demonstrated the anomalous origin of the LMCA from the right coronary sinus of Valsalva, with a retro-pulmonary inter-arterial course of the vessel. The proximal LMCA was tortuous with a severe 'fish mouth' narrowing followed by a distal eccentric, non-obstructive mixed plaque confined to the wall and not causing any luminal stenosis ( Figure 2) .
Subsequently, the patient underwent coronary artery bypass graft (CABG) surgery. The LIMA was anastomosed to the distal left anterior descending artery, and a saphenous vein graft was anastomosed to the first obtuse marginal branch. The procedure was uncomplicated and the patient recovered uneventfully, however, a follow-up surveillance CTCA unfortunately demonstrated atresia of the LIMA graft ( Figure 3) . The vein graft remained patent. After 7 years, the patient underwent a repeat surveillance CTCA following a normal stress echocardiogram, which demonstrated recanalization and patency of the LIMA graft with good distal runoff ( Figure 4) . The distal left main at this time demonstrated a large, though non-obstructive, mixed plaque just proximal to the bifurcation ( Figure 5 ).
Discussion
The anomalous origin of one or more coronary arteries is a wellestablished entity. Despite the rarity of this phenomenon, with an incidence of approximately 1.3%, 1 anomalous anatomy that portends a potentially lethal prognosis; included in this population are those with a left coronary origin from the pulmonary artery or the right coronary sinus, a right coronary artery from the left coronary sinus, and those with a single coronary artery or coronary artery fistulae. The origin of the LMCA from the right coronary sinus accounts for 0.15-1.3% of variants, 1,2 and this anomaly itself has multiple subtypes, of which the rarest and most lethal is the inter-arterial, or 'malignant', course of the left main between the aorta and pulmonary artery. It has been postulated that the cross-sectional expansion of the great vessels during exertion leads to functional compression of the inter-arterial coronary artery, 1,2 however, there is a paucity of robust pathophysiological evidence. Due to the potential for sudden death amongst this phenotype, surgical correction is recommended irrespective of the presence of symptoms. 3 Gulati et al. 3 demonstrated viability of pulmonary artery translocation in two patients as a means of mitigating functional compression of the entrapped coronary artery, which can also be achieved with coronary button reimplantation. Coronary artery bypass graft surgery serves to bypass the malignant course of the LMCA, and is the favoured treatment in patients with underlying coronary disease, 4 however, there is concern that this option may lead to graft atresia due to competitive flow in the native vessel in patients without obstructive coronary disease. Cases reporting the recanalization of IMA grafts following CABG are exceptionally scarce, and, to the best of our knowledge, we present here the first case documenting the restoration of LIMA patency after bypass surgery for an anomalous left main origin. We postulate that the dynamic obstruction of the anomalous inter-arterial LMCA led to variable flow dependence on the bypass graft and subsequent atresia of the LIMA, due to the favourable native flow conditions in the absence of significant obstructive coronary disease. The preservation of the saphenous vein graft patency may be explained by the known differences between arterial and vein graft flow dynamics. 10 The flow reserve of vein grafts remains stable with time. However, in the new LIMA graft, there is higher flow velocities and restricted flow capacity, mediated by a smaller diameter. Though this improves with time, in the early post-operative period this phenomenon may jeopardise LIMA patency in the absence of obstructive native disease.
The fact that there had not been a notable increase in the burden of coronary disease over the seven year period confounds the theory that dependence on the bypass graft was mediated by progressive native coronary obstruction. It is possible that the small increase in size of the distal left main plaque ( Figure 5) , though non-obstructive, may have had a minor contribution to dynamic native flow impedance, thereby tipping the balance of favourability to the LIMA, though the exact mechanism remains unclear. Serial invasive measurement of LMCA fractional flow reserve could offer additional information regarding the degree to which the left main plaque contributes to flow limitation, but given the lack of symptoms and normal exercise capacity of the patient, invasive assessment has not been pursued.
Conclusion
Here, we present the first documented case of restored LIMA patency post bypass surgery for a malignant anomalous course of the LMCA. Though this is a rare phenomenon, care should be taken in selecting the best revascularization strategy in patients with anomalous anatomy to best protect against the potentially lethal outcomes of the disease. In particular, patients without flow limiting atherosclerotic disease may carry an additional risk of graft occlusion due to preserved native coronary flow. Further studies are required to both elucidate the exact underlying pathophysiological mechanism or graft recanalization and to assist better risk stratification of patients.
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